Ocean Spray celebrates newest state-of-the-art facility
LAKEVILLE-MIDDLEBORO, Mass. — Ocean Spray Cranberries, an agricultural cooperative and producer of cranberry products, on Tuesday celebrated the grand opening of its newest beverage facility in the Upper Macungie Township of Pennsylvania. The plant is the company’s first in the state and will handle about 40% of the cooperative’s North American volume once it’s fully operational later this year.
“The Grower-Owners of Ocean Spray Cranberries have made a major investment here in Pennsylvania, and today’s celebration is the result of a lot of hard work by our employees and partners on this project,” said Randy Papadellis, president and CEO of Ocean Spray. “As a cooperative founded on the work ethic and values of its many Grower-Owners, Ocean Spray is committed to bringing a neighborly culture everywhere we do business. We are pleased to be joining the Lehigh Valley community, and we look forward to being a part of the Pennsylvania economy for many decades to come.”
Ocean Spray broke ground on the 44-acre site in April 2012, and more than 1,000 workers put in countless hours to build the nearly 300,000 sq.-ft. plant. It will be responsible for generating 30 million cases of Ocean Spray juice beverages each year, which range from 100% cranberry juice to blends made with blueberry, grapefruit, pomegranate and other juices.
“This state-of-the-art facility truly does represent Ocean Spray’s commitment to the future,” said Erich Fritz, VP of engineering and new technologies for Ocean Spray, who has overseen the design and construction of the new beverage facility. “The Lehigh Valley facility is truly innovative with technology and systems designed to provide efficiency and major energy savings now and in the future.”
Horizon announces new line of snack products
BROOMFIELD, Colo. — Horizon, a national organic dairy brand, on Tuesday announced the launch of a line of new snack products, which include Horizon Snack Crackers, Sandwich Crackers and Snack Grahams. These items are part of the company’s journey outside of the dairy case and come on the heels of several Mac & Cheese products in January.
Horizon is introducing both organic and made-with-organic options. The USDA-certified organic snacks include Horizon Organic Sandwich Crackers in cheddar and peanut butter varieties. The crackers are packaged in a multi-serve 7.5-oz. box
The made-with-organic snacking products include Horizon Snack Crackers in cheddar and original varieties, which come in a 6.6-oz. box; and Horizon Snack Grahams in honey, cinnamon and chocolate flavors. The snack grahams are available in a multi-serve 7.5-oz. box
“Horizon snack products are a perfect choice for busy families looking for great tasting snacks made with the goodness of organic ingredients,” said Mike Ferry, president of Horizon. “We are always looking for new ways to introduce consumers to the benefits of organic, and with these new options, Horizon now offers more organic products to consumers than ever before.”
Horizon snack products can be found in the snack aisle in grocery stores nationwide.
FDA grants accelerated approval to Zykadia
SILVER SPRING, Md. — The Food and Drug Administration on Tuesday granted approval to Zykadia (ceritinib) for patients with a specific type of late-stage (metastatic) non-small cell lung cancer (NSCLC).
The drug — an anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitor — blocks proteins that promote the development of cancerous cells and is intended for patients with metastatic ALK-positive NSCLC who were previously treated with crizotinib.
"Today’s approval illustrates how a greater understanding of the underlying molecular pathways of a disease can lead to the development of specific therapies aimed at these pathways,” said Richard Pazdur, M.D., director of the Office of Hematology and Oncology Products in the FDA’s Center for Drug Evaluation and Research. “It also demonstrates the FDA’s commitment to working cooperatively with companies to expedite a drug’s development, review and approval, reflecting the promise of the breakthrough therapy designation program.”
Zykadia is marketed by Novartis, which is based in East Hanover, N.J.